Dx dialogues: versatile treatment options across the multiple myeloma landscape
Douglas W. Sborov, MD shares treatment options across the multiple myeloma landscape.
Up next
Jan 14, 2026
Dx dialogues: post anti-CD38 therapy
Dx dialogues: helping physicians identify patients for combination therapies with CAR-T
Dx dialogues: other potential treatments for indolent systemic mastocytosis
Advocating for yourself with multiple myeloma
Dec 28, 2022
Dx dialogues: advancements in treating indolent systemic mastocytosis
Access to care for multiple myeloma
What you need to know about multiple myeloma
Jul 25, 2017
My experience being diagnosed with multiple myeloma
Jan 12, 2023
The importance of finding the right doctor
The importance of advocacy for multiple myeloma